Lipotriche scandens
Lipotriche scandens · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Lipotriche scandens is a climbing plant that has garnered scientific interest due to its significant pharmacological potential. Research indicates that its leaves contain bioactive compounds, most notably 3-O-beta-D-glucuronopyranosyl oleanolic acid. When prepared as aqueous or ethanolic extracts, the plant demonstrates promising anticonvulsant and anxiolytic activities. These medicinal properties suggest that the species may play a role in managing neurological conditions such as epilepsy. Consequently, studying this plant offers valuable insights into natural approaches for treating central nervous system disorders.
- Synonyms
- Melanthera Scandens · Amellus Scandens · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Lipotriche scandens is a botanical species that has been identified under several different names throughout scientific history. Due to taxonomic shifts, it is formally recognized by the synonym Amellus scandens. Researchers have also categorized this plant as Buphthalmum scandens in various studies. Furthermore, the name Melanthera scandens serves as another established synonym for the species. Understanding these multiple nomenclatures is essential for accurately tracking the plant's classification in botanical records.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lipotriche scandens belongs to the vast kingdom Plantae, representing a diverse branch of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its evolutionary connections to other flowering plants. As a member of the family Asteraceae, it shares characteristics with many well-known composite flowers. Ultimately, this plant is identified by its specific genus, Lipotriche.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Lipotriche |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lipotriche scandens is a notable plant species with a broad distribution spanning across the African continent. Within East Tropical Africa, it can be found growing in the diverse landscapes of Kenya, Tanzania, and Uganda. The species also extends its reach into Northeast Tropical Africa, establishing itself in the regions of Chad and Ethiopia. This wide geographical range highlights the plant's ability to adapt to various tropical environments. Ultimately, its presence across these multiple nations underscores its ecological significance within the African tropics.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lipotriche scandens is a distinctive herb characterized by its self-supporting growth form. This plant typically reaches a modest height of approximately one meter during its development. Under optimal conditions, it can extend slightly further, reaching a maximum height of 1.29 meters. Its compact stature makes it a unique addition to its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lipotriche scandens, also referred to in research as Melanthera scandens, has demonstrated significant pharmacological potential in recent animal studies. Scientific investigations into its aqueous and ethanolic leaf extracts reveal that the plant possesses notable anticonvulsant activity. Specifically, these extracts have been shown to reduce seizure severity and provide protection against death in rat models. Furthermore, the plant exhibits anxiolytic activity, which was evidenced by increased exploratory behavior in elevated plus maze tests. These findings suggest that the phytochemical constituents of the plant could serve as a valuable source for developing new treatments for epilepsy and anxiety.
Compounds
Lipotriche scandens, also known as Melanthera scandens, serves as a significant source of diverse triterpenoid saponins. Through the application of 2D NMR techniques, including ROESY, researchers have successfully elucidated the complex structures of several compounds isolated from its leaves. Among these identified substances is the specific compound 3-O-beta-D-glucuronopyranosyl oleanolic acid. The plant also yields more intricate variations, such as branched glycosides and corresponding 28-O-beta-D-glucosides. These findings highlight the chemical richness of the species and its potential value in phytochemical studies.
Conditions
Lipotriche scandens (referred to as Melanthera scandens in the study) demonstrates significant medicinal potential by treating epilepsy through its anticonvulsant properties. Research indicates that the plant's extracts effectively treat the pentylenetetrazol (PTZ)-induced seizure model in rats. Furthermore, the extracts provide critical protection by treating PTZ-induced death at specific dosage levels. The plant also exhibits anxiolytic activity, helping to reduce anxiety in experimental models. These combined effects highlight the plant's ability to manage both seizure activity and associated psychological distress.
Preparations
Lipotriche scandens is prepared as aqueous extracts for scientific investigation into its medicinal properties. These aqueous preparations are studied alongside ethanolic extracts to evaluate their phytochemical content. The plant is also prepared as ethanolic extracts to test for specific biological activities in animal models. Research utilizes both aqueous and ethanolic forms to assess anticonvulsant and anxiolytic effects. Consequently, these two distinct extraction methods serve as the primary means of analyzing the plant's therapeutic potential.
Parts used
Lipotriche scandens, also known by its synonym Melanthera scandens, offers significant pharmacological potential through its various botanical components. Research highlights that the leaf of this plant is particularly valuable for its diverse phytochemical properties. Studies have successfully isolated several triterpenoid saponins directly from these leaves using advanced structural elucidation techniques. Furthermore, aqueous and ethanolic extracts derived from the foliage have demonstrated both anticonvulsant and anxiolytic activities in animal models. These findings suggest that the leaf serves as a critical source for developing new medicinal treatments for neurological conditions.